https://www.selleckchem.com/products/nd-630.html
We conducted a prospective study to evaluate a new hemorrhoidal bleeding score (HBS). All consecutive patients who had consulted between May 1, 2016, and June 30, 2017 for bleeding hemorrhoidal disease were prospectively assessed at a proctological department. The study was conducted in two stages. A first stage assessed the validity of the score on a prospective patient cohort. A second stage assessed the interobserver reproducibility of the score on another prospective cohort. One hundred consecutive patients were studied (57 men, mean
Aimer
Commentaire
Partagez
